In summary, our study suggests that CL-11, a recently described component of innate immunity, is of relevance to the inflammatory status of RPE cells and may thus play an important role in AMD pathogenesis and the outcome of therapeutic interventions. The gene discussed is COLEC11; the disease is age-related macular degeneration.